Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MEDCO PLANS WITH INCENTIVE-BASED OR CLOSED FORMULARIES COVER 3% OF MEMBERS; GAO SAYS FTC SHOULD CONTINUE CLOSE MONITORING OF PBM/MANUFACTURER RELATIONSHIPS

Executive Summary

Four out of more than 2,000 Medco plans have adopted an incentive-based or closed formulary, a Nov. 9 General Accounting Office report on pharmaceutical benefit managers states. Of approximately 90 formularies managed by SmithKline Beecham-owned Diversified Pharmaceutical Services, one-third are incentive-based or closed.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027203

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel